Incidental Mutation 'R2512:Aplp2'
ID 253462
Institutional Source Beutler Lab
Gene Symbol Aplp2
Ensembl Gene ENSMUSG00000031996
Gene Name amyloid beta precursor-like protein 2
Synonyms
MMRRC Submission 040418-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R2512 (G1)
Quality Score 225
Status Not validated
Chromosome 9
Chromosomal Location 31060853-31123111 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to T at 31078973 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Arginine to Histidine at position 325 (R325H)
Ref Sequence ENSEMBL: ENSMUSP00000149732 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000072634] [ENSMUST00000079758] [ENSMUST00000213254] [ENSMUST00000217641]
AlphaFold Q06335
Predicted Effect probably damaging
Transcript: ENSMUST00000072634
AA Change: R325H

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000072428
Gene: ENSMUSG00000031996
AA Change: R325H

DomainStartEndE-ValueType
signal peptide 1 31 N/A INTRINSIC
A4_EXTRA 42 204 7.91e-123 SMART
low complexity region 218 232 N/A INTRINSIC
coiled coil region 242 269 N/A INTRINSIC
KU 308 361 3.52e-24 SMART
Pfam:APP_E2 365 547 1.6e-71 PFAM
low complexity region 555 568 N/A INTRINSIC
low complexity region 589 595 N/A INTRINSIC
low complexity region 597 609 N/A INTRINSIC
Pfam:APP_amyloid 697 747 1.5e-27 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000079758
SMART Domains Protein: ENSMUSP00000078694
Gene: ENSMUSG00000031996

DomainStartEndE-ValueType
signal peptide 1 31 N/A INTRINSIC
A4_EXTRA 42 204 7.91e-123 SMART
low complexity region 218 232 N/A INTRINSIC
coiled coil region 242 269 N/A INTRINSIC
Pfam:APP_E2 307 492 2.3e-75 PFAM
low complexity region 499 512 N/A INTRINSIC
low complexity region 533 539 N/A INTRINSIC
low complexity region 541 553 N/A INTRINSIC
Pfam:APP_amyloid 652 703 1.5e-32 PFAM
Predicted Effect probably damaging
Transcript: ENSMUST00000213254
AA Change: R325H

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
Predicted Effect noncoding transcript
Transcript: ENSMUST00000214908
Predicted Effect noncoding transcript
Transcript: ENSMUST00000217516
Predicted Effect probably benign
Transcript: ENSMUST00000217641
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.6%
  • 10x: 97.4%
  • 20x: 95.2%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes amyloid precursor- like protein 2 (APLP2), which is a member of the APP (amyloid precursor protein) family including APP, APLP1 and APLP2. This protein is ubiquitously expressed. It contains heparin-, copper- and zinc- binding domains at the N-terminus, BPTI/Kunitz inhibitor and E2 domains in the middle region, and transmembrane and intracellular domains at the C-terminus. This protein interacts with major histocompatibility complex (MHC) class I molecules. The synergy of this protein and the APP is required to mediate neuromuscular transmission, spatial learning and synaptic plasticity. This protein has been implicated in the pathogenesis of Alzheimer's disease. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
PHENOTYPE: Homozygotes for two different targeted alleles show embryonic lethality, or viability and fertility with increased copper levels in cerebral cortex and liver. Double knockouts with App show high mortality, reduced growth, and neurological symptoms. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 71 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
2700049A03Rik A G 12: 71,219,945 (GRCm39) T831A possibly damaging Het
Actg2 T A 6: 83,503,829 (GRCm39) I72F probably damaging Het
Add1 A G 5: 34,774,030 (GRCm39) T80A probably benign Het
Alpk2 G A 18: 65,483,591 (GRCm39) T139M probably damaging Het
Aptx G A 4: 40,694,917 (GRCm39) P140S probably benign Het
Carm1 A G 9: 21,486,708 (GRCm39) probably null Het
Carmil2 A T 8: 106,424,025 (GRCm39) I1293F probably benign Het
Cdh8 T C 8: 100,127,495 (GRCm39) T39A probably benign Het
Cimip3 T C 17: 47,724,651 (GRCm39) T60A probably benign Het
Col15a1 T A 4: 47,245,868 (GRCm39) N206K possibly damaging Het
Copg2 C T 6: 30,873,591 (GRCm39) probably null Het
Ctr9 T G 7: 110,646,078 (GRCm39) I690S probably damaging Het
Dcaf8 T G 1: 172,016,602 (GRCm39) I463S possibly damaging Het
Dcp1b G T 6: 119,183,473 (GRCm39) A187S possibly damaging Het
Ddo T A 10: 40,508,935 (GRCm39) D58E possibly damaging Het
Dkkl1 G T 7: 44,857,157 (GRCm39) R137S probably damaging Het
Dxo A G 17: 35,056,718 (GRCm39) N115S probably benign Het
Ep400 A T 5: 110,856,781 (GRCm39) probably benign Het
F11 A G 8: 45,714,098 (GRCm39) V7A probably benign Het
Fermt1 G T 2: 132,781,438 (GRCm39) probably null Het
Fign A T 2: 63,810,143 (GRCm39) F376I probably benign Het
Flg2 G T 3: 93,109,082 (GRCm39) G370V probably damaging Het
Fndc3a A T 14: 72,793,715 (GRCm39) D953E probably benign Het
Fsip2 A T 2: 82,808,511 (GRCm39) H1610L probably benign Het
Gfra3 T C 18: 34,837,564 (GRCm39) N145D probably benign Het
Inpp4b G T 8: 82,737,179 (GRCm39) W525C probably damaging Het
Kremen1 CGGG CGGGGGG 11: 5,151,791 (GRCm39) probably benign Het
Lgi2 A G 5: 52,695,307 (GRCm39) *543R probably null Het
Lyn A G 4: 3,745,542 (GRCm39) T114A probably benign Het
Lynx1 A G 15: 74,623,169 (GRCm39) Y88H probably damaging Het
Map4 C A 9: 109,863,770 (GRCm39) P332T possibly damaging Het
Mapk8ip3 A T 17: 25,133,677 (GRCm39) C250* probably null Het
Metap1d A G 2: 71,352,954 (GRCm39) H261R probably damaging Het
Mfrp T C 9: 44,013,835 (GRCm39) V115A probably benign Het
Mtbp A G 15: 55,440,932 (GRCm39) Y373C probably damaging Het
Mtor C A 4: 148,614,948 (GRCm39) R1628S possibly damaging Het
Muc5b A G 7: 141,412,813 (GRCm39) N1920D unknown Het
Myo1d T A 11: 80,670,543 (GRCm39) M26L probably benign Het
Neb A C 2: 52,100,843 (GRCm39) D643E probably damaging Het
Nme1 A G 11: 93,851,513 (GRCm39) F108L possibly damaging Het
Or2r11 A G 6: 42,437,207 (GRCm39) S249P probably damaging Het
Or8c15 G T 9: 38,120,670 (GRCm39) C54F probably damaging Het
Pan2 T A 10: 128,140,326 (GRCm39) D82E probably damaging Het
Pclo A G 5: 14,762,612 (GRCm39) D3695G unknown Het
Pcnx4 A T 12: 72,603,573 (GRCm39) probably null Het
Plg A G 17: 12,622,116 (GRCm39) T479A probably benign Het
Plod3 G C 5: 137,017,000 (GRCm39) A50P probably benign Het
Pramel32 T G 4: 88,547,195 (GRCm39) M246L probably damaging Het
Ptgis T C 2: 167,049,196 (GRCm39) D372G probably damaging Het
Ranbp3l A G 15: 8,997,949 (GRCm39) T14A probably benign Het
Rcc1l A T 5: 134,195,508 (GRCm39) V230D probably damaging Het
Reln T C 5: 22,184,688 (GRCm39) D1609G possibly damaging Het
Rif1 GCCACCA GCCA 2: 52,000,336 (GRCm39) probably benign Het
Ryr1 G A 7: 28,802,967 (GRCm39) L696F possibly damaging Het
Sacs T A 14: 61,440,529 (GRCm39) D858E probably benign Het
Sec16a C T 2: 26,329,037 (GRCm39) V993I probably benign Het
Skint5 T A 4: 113,487,616 (GRCm39) I901F unknown Het
Slc17a3 A T 13: 24,030,230 (GRCm39) I114F probably benign Het
Slc17a7 T A 7: 44,818,288 (GRCm39) L71Q probably damaging Het
Slc43a2 T C 11: 75,461,403 (GRCm39) S452P probably damaging Het
Smarca4 A G 9: 21,546,994 (GRCm39) N173S possibly damaging Het
Tbc1d21 T C 9: 58,270,195 (GRCm39) Y161C probably damaging Het
Tpsab1 C A 17: 25,564,081 (GRCm39) C94F probably damaging Het
Ubr5 G A 15: 38,002,563 (GRCm39) P1496L probably damaging Het
Unc80 G T 1: 66,710,767 (GRCm39) A2679S possibly damaging Het
Vdac1 T A 11: 52,274,904 (GRCm39) V184E probably damaging Het
Vmn2r24 T A 6: 123,763,985 (GRCm39) S287R probably benign Het
Vmn2r91 T C 17: 18,356,048 (GRCm39) F572L probably benign Het
Vps13b G A 15: 35,884,701 (GRCm39) E3125K probably benign Het
Ythdf3 A G 3: 16,259,059 (GRCm39) N406S possibly damaging Het
Zfp708 T C 13: 67,219,251 (GRCm39) K158E probably damaging Het
Other mutations in Aplp2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02067:Aplp2 APN 9 31,062,191 (GRCm39) missense probably damaging 1.00
IGL02152:Aplp2 APN 9 31,122,947 (GRCm39) missense unknown
IGL02309:Aplp2 APN 9 31,078,979 (GRCm39) missense possibly damaging 0.80
IGL02407:Aplp2 APN 9 31,069,823 (GRCm39) nonsense probably null
IGL02623:Aplp2 APN 9 31,089,379 (GRCm39) splice site probably benign
IGL02737:Aplp2 APN 9 31,064,712 (GRCm39) missense probably benign
IGL02958:Aplp2 APN 9 31,075,972 (GRCm39) splice site probably benign
R0211:Aplp2 UTSW 9 31,069,086 (GRCm39) missense probably damaging 0.99
R0279:Aplp2 UTSW 9 31,069,086 (GRCm39) missense probably damaging 0.99
R1669:Aplp2 UTSW 9 31,079,029 (GRCm39) intron probably benign
R1707:Aplp2 UTSW 9 31,062,215 (GRCm39) missense probably damaging 1.00
R1755:Aplp2 UTSW 9 31,088,400 (GRCm39) missense probably damaging 1.00
R2842:Aplp2 UTSW 9 31,069,122 (GRCm39) missense probably benign 0.12
R4031:Aplp2 UTSW 9 31,069,026 (GRCm39) missense probably benign 0.00
R4115:Aplp2 UTSW 9 31,069,122 (GRCm39) missense probably benign 0.12
R5725:Aplp2 UTSW 9 31,069,110 (GRCm39) missense probably damaging 1.00
R6032:Aplp2 UTSW 9 31,062,240 (GRCm39) missense probably damaging 1.00
R6032:Aplp2 UTSW 9 31,062,240 (GRCm39) missense probably damaging 1.00
R6375:Aplp2 UTSW 9 31,069,084 (GRCm39) missense probably benign 0.00
R7170:Aplp2 UTSW 9 31,081,739 (GRCm39) missense probably benign 0.03
R7541:Aplp2 UTSW 9 31,063,652 (GRCm39) missense possibly damaging 0.82
R7584:Aplp2 UTSW 9 31,069,077 (GRCm39) missense possibly damaging 0.56
R7711:Aplp2 UTSW 9 31,072,645 (GRCm39) missense probably damaging 1.00
R8092:Aplp2 UTSW 9 31,074,640 (GRCm39) critical splice donor site probably null
R8367:Aplp2 UTSW 9 31,089,202 (GRCm39) missense probably damaging 1.00
R9343:Aplp2 UTSW 9 31,122,935 (GRCm39) missense unknown
R9400:Aplp2 UTSW 9 31,075,855 (GRCm39) missense possibly damaging 0.89
R9711:Aplp2 UTSW 9 31,083,303 (GRCm39) missense probably benign 0.05
Z1187:Aplp2 UTSW 9 31,063,637 (GRCm39) missense possibly damaging 0.70
Predicted Primers PCR Primer
(F):5'- TGACAGATGCAGTCACAAGG -3'
(R):5'- GAAAGTGCTTCTGTTTGCCTC -3'

Sequencing Primer
(F):5'- GTCACAAGGACAGCCAGG -3'
(R):5'- AAAGTGCTTCTGTTTGCCTCTATTG -3'
Posted On 2014-12-04